What is the appropriate management for an 80‑year‑old man with benign prostatic hyperplasia who has a catheter‑associated urinary tract infection presenting with hematuria and clots in the Foley bag and persistent bacteriuria after five days of empiric antibiotics despite resolution of fever?

Management of Catheter-Associated UTI with Hematuria and Persistent Bacteriuria in an 80-Year-Old Man with BPH

Replace the Foley catheter immediately before obtaining a urine culture and before starting new antibiotics, then switch to culture-directed therapy for 10–14 days given the delayed clinical response. 1

Immediate Catheter Management

• Replace the catheter now because it has been in place for at least 5 days (likely longer given the chronic BPH history), and catheter replacement before initiating antimicrobial therapy significantly decreases polymicrobial bacteriuria, shortens time to clinical improvement (p < 0.001), and lowers CA-UTI recurrence within 28 days (p = 0.015). 1

• Collect the urine culture specimen from the newly placed catheter, not from the old catheter or drainage bag, to avoid false-positive results caused by biofilm colonization on the old device. 1

• The hematuria with clots is likely related to catheter trauma, biofilm disruption, or underlying prostatic bleeding from BPH; replacing the catheter will help resolve this mechanical issue while addressing the infection. 2, 3

Reassess Antibiotic Therapy

• Obtain blood cultures immediately if not already done, because approximately 20% of hospital-acquired bacteremias arise from the urinary tract in catheterized patients, and this patient has had persistent infection despite 5 days of antibiotics. 2

• Review the urine culture and susceptibility results from the initial presentation (if available) to determine whether the current antibiotics cover the isolated organism; persistent bacteriuria after 5 days suggests either resistant organisms or inadequate source control (the old catheter). 2, 1

• Switch to culture-directed narrow-spectrum therapy once new culture results are available, prioritizing the most effective agent with the narrowest spectrum to limit resistance development. 1

Empiric Antibiotic Selection (If Culture Results Pending)

• For an 80-year-old man with BPH and CA-UTI, empiric therapy should cover multidrug-resistant organisms common in complicated UTI, including E. coli, Proteus, Klebsiella, Pseudomonas, and Enterococcus species. 2

• First-line empiric options include:

  • Intravenous third-generation cephalosporin (ceftriaxone 1–2 g daily or cefepime 1–2 g twice daily) 2, 1
  • Amoxicillin plus an aminoglycoside 2
  • Second-generation cephalosporin plus an aminoglycoside 2

• Avoid fluoroquinolones (ciprofloxacin, levofloxacin) for empiric therapy in this patient because he is from a urology population (BPH with chronic catheter issues) where resistance rates commonly exceed 10%, and fluoroquinolones should not be used empirically in urology patients or those who have received them in the last 6 months. 2, 1

Treatment Duration

• Extend treatment to 10–14 days rather than the standard 7-day course because this patient has demonstrated a delayed clinical response (persistent infection after 5 days, though fever has resolved). 2, 1

• The patient has been afebrile for an unspecified period; if he has been afebrile for at least 48 hours and is hemodynamically stable, a 7-day course could be considered, but given the persistent bacteriuria, 10–14 days is safer and more appropriate. 2, 1

• In men with CA-UTI, 14 days is generally recommended when prostatitis cannot be excluded, which is relevant in this 80-year-old with BPH. 2

Evaluation for Persistent Infection

• If fever recurs or bacteriuria persists beyond 72 hours of appropriate therapy for a susceptible organism, promptly evaluate for:

  • Bloodstream infection (obtain blood cultures) 1
  • Prostatic abscess (consider transrectal ultrasound or CT imaging) 1
  • Bladder outlet obstruction from BPH causing incomplete bladder emptying and persistent infection 4, 5
  • Upper urinary tract involvement (hydronephrosis, pyelonephritis, or renal abscess) requiring imaging with renal ultrasound or CT 1, 4

• Imaging of the upper urinary tract is recommended in men with complicated UTI and BPH to identify underlying abnormalities such as hydronephrosis, which occurred in 4 cases in one study of BPH patients with post-void residual volumes of 301–400 cc. 3, 4

Management of Hematuria and Clots

• The hematuria with clots in the Foley bag is a common complication in catheterized patients with BPH; in one study, 51% of catheterized BPH patients reported hematuria. 3

• Ensure adequate catheter drainage to prevent clot retention and bladder distension; if clots are obstructing the catheter, consider continuous bladder irrigation with a three-way catheter until hematuria clears. 2

• Do not attribute the hematuria solely to infection; acute hematuria is a sign compatible with CA-UTI, but in BPH patients it may also result from prostatic bleeding, catheter trauma, or bladder mucosal irritation. 2, 3

Address the Underlying BPH

• Recurrent or persistent UTI in men with BPH is an indication for surgical treatment (transurethral resection of the prostate or other BPH procedures) to relieve bladder outlet obstruction and prevent future infections. 4

• Bladder outlet obstruction secondary to BPH is a major cause of UTI in men, and definitive management of the urological abnormality is mandatory to prevent recurrent infections. 2, 4

• Screening for bacteriuria and treating it before any urological procedure (such as TURP) is recommended to prevent post-procedure sepsis. 4

Critical Pitfalls to Avoid

• Do not delay catheter replacement if the catheter has been in place ≥2 weeks (or even ≥5 days in this case); this is crucial for treatment success and should be done before starting new antibiotics. 1

• Do not treat asymptomatic bacteriuria once the acute infection resolves; if the patient becomes asymptomatic after treatment, do not continue antibiotics or obtain surveillance cultures, as this increases antimicrobial resistance without preventing future CA-UTI. 2, 1

• Do not administer prophylactic antibiotics for chronic catheter management after the acute infection is treated; prophylaxis does not reduce symptomatic CA-UTI rates and promotes resistance. 2, 1

• Do not collect urine from the drainage bag for culture; this leads to false-positive results due to bacterial multiplication in the bag. 1

• Do not assume the infection is controlled simply because fever has resolved; persistent bacteriuria after 5 days of antibiotics indicates either resistant organisms, inadequate source control (old catheter), or an alternative infection source requiring further evaluation. 1